Data form TARA trial Taper in RA remission Flare free survival at 2 yrs 35% Risk of flare is similar in ACPA+ & ACPA

Social Author Image
https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg
Tweet Author
AurelieRheumo
Social Author Name
Aurelie Najm
Tweet Content
Data form TARA trial Taper in RA remission Flare free survival at 2 yrs 35% Risk of flare is similar in ACPA+ & ACPA- RA Risk of flare is similar if taper TNFi first or csDMARD first @RheumNow #EULAR2024 POS0405 https://t.co/89gAglHUcw
Links
https://twitter.com/AurelieRheumo/status/1801925729971569102/photo/1
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×